BusinessEPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 15, 2016, 10:00 AM UTC
BusinessEPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Provide Business UpdateBy Nasdaq OMXMar 1, 2016, 1:00 PM UTC
BusinessEPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for BOW015 (Infliximab Biosimilar)By Nasdaq OMXFeb 9, 2016, 12:00 PM UTC
BusinessEPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare Event on February 12By Nasdaq OMXFeb 5, 2016, 9:01 PM UTC
BusinessEPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global Healthcare ConferenceBy Nasdaq OMXFeb 3, 2016, 2:00 PM UTC
